Indicators

Latest News about disease

Recent news which mentions disease

Cancer Centers Race To Access Revolution Medicines' Pancreatic Cancer Treatment: Report

May 15, 2026

Protara Therapeutics Reports 55% Complete Response Rate In Bladder Cancer Study

May 15, 2026

REGENXBIO Advances Duchenne Gene Therapy Toward Accelerated Approval

May 14, 2026

Recursion Eyes Breakthrough With REC-4881 Drug For Rare Genetic Condition, But Shares Pull Back

May 07, 2026

Penny Stock Oncolytics Biotech Says Colorecatal Cancer Drug's Durability Tops Historical Benchmarks

May 04, 2026

Gilead's Lenacapavir Plan Faces Global Hurdles As It Commits To No-Profit Access for 2 Million

July 09, 2025

Capricor Reports 4-Year Data For Deramiocel, Shows Sustained Benefit In Duchenne Patients

June 20, 2025

European Advisory Panel Backs Conditional Approval For Madrigal's Fatty Liver Disease Drug

June 20, 2025

Omeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA Decision

June 10, 2025

Pfizer, Arvinas Partnered Breast Cancer Drug Cuts Progression Risk By 43% In Trial, Seeks FDA Approval

June 06, 2025

Valneva's Chikungunya Vaccine Advances With Pediatric Trial, Phase 3 In 2026

June 05, 2025

Jazz Pharma's Zepzelca Combo Shows Survival Edge In Lung Cancer Study

June 03, 2025

Trevi Therapeutics Showcases Drug That Cuts Cough Frequency In Lung Disease Patients

June 02, 2025

Bicara Therapeutics Shares Sink Over 43% On Mixed Phase 1/1b Trial Results: What's Going On?

May 23, 2025

Brazil Approves Valneva's Mosquito-Borne Chikungunya Vaccine

April 14, 2025

Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success

April 10, 2025

Cartesian Therapeutics Reports Strong 12-Month Data For Lead Cell Therapy In Myasthenia Gravis Patients

April 08, 2025

Edgewise Therapeutics Sees Meaningful HCM Treatment Gains With EDG-7500 In Phase 2 Study

April 02, 2025

Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Data

March 31, 2025

Why Is Portage Biotech Stock Skyrocketing Friday?

March 28, 2025

FDA Approves Exelixis' Lead Cancer Drug Cabometyx For Expanded Use In Neuroendocrine Tumors

March 26, 2025

Crinetics Pharmaceuticals Analyst Sees Around 70% Upside For Stock, Cites More Investor Interest In Endocrinology

March 25, 2025

Johnson & Johnson's Golden Cross: Technical Momentum Meets Groundbreaking Lung Cancer Breakthrough

March 20, 2025

Regenxbio Touts Positive Biomarker Data From Duchenne Muscular Dystrophy Gene Therapy Trial

March 19, 2025

AbbVie's Elahere Cuts Death Risk By 32%, Shows Consistent Survival Benefit In Long-Term Analysis For Certain Ovarian Cancer Patients

March 17, 2025

Avidity Biosciences Touts Positive Data From Early-Stage Duchenne Muscular Dystrophy Study Data, FDA Submission Expected By End Of 2025

March 17, 2025

Pliant Therapeutics' Investigational Cancer Drug Shows Antitumor Activity Across Multiple Tumor Types

March 17, 2025

Scholar Rock Stock Jumps On Additional Data From Pivotal Trial Of Muscular Dystrophy Treatment

March 17, 2025

Perspective Therapeutics' Cancer-Focused Radiotherapy Portfolio Has Upside Potentional, Says Analyst

March 13, 2025

Cannabis Takes On Superbugs: Could This New Drug 'Change Infection Treatment Forever'?

February 05, 2025

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.